Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Category: Uncategorized
-
By Kevin E. Noonan — The advent of a new administration always carries with it changes in how the laws are executed and applied, and patent law is both no exception and tends (at least in recent years) to appear to be fraught with dramatic changes in emphasis (at least on certain aspects of the…
-
To paraphrase Chicago Bulls legend, Michael Jordan, Patent Docs would like to announce that we are back! A few of our readers have noticed that it has been awhile since we last posted, and you may have noticed that there were a few “issues” with the way Patent Docs appeared on your browser earlier this…
-
By Kevin E. Noonan — On April 29th, Ambassador Jamieson Greer, U.S. Trade Representative (USTR), issued the 2025 Special 301 Report. In a press release (being quite different in tone from many over the past decade), the USTR stated that "[o]ur trading partners must address the concerns identified in the Special 301 Report and stop those…
-
The Buckeye Institute Files Amicus Brief in Newman v. Moore et al. By Kevin E. Noonan — It has been a remarkable feature of the Federal Circuit's suspension of the Honorable Judge Pauline Newman that few have taken a stand publicly on the propriety of the suspension (something the Judge herself recently mentioned; see "An American…
-
By Donald Zuhn –- After reflecting upon the events of the past twelve months, Patent Docs presents its 17th annual list of top patent stories. For 2023, we identified ten stories that were covered on Patent Docs last year that we believe had (or are likely to have) a significant impact on patent practitioners and…
-
The American Conference Institute (ACI) will be presenting its 9th Annual Paragraph IV Disputes Master Symposium on October 24-25, 2023 in Chicago, IL. As in the past, this curated program will not only address "hot" topics but also will put the issues within the context of pre-suit considerations, case filings, final adjudication, and every step…
-
Patent Docs has always ascribed to the notion that respectful debate is good for most issues, and with the adage that if you are dumb, it's best to surround yourself with smart people and if you are smart surround yourself with smart people who disagree with you. In that spirit we give our readers the…
-
But Not All the Judges Are Happy About It By Kevin E. Noonan — On March 16th, the Federal Circuit denied Biogen's petition for panel rehearing and rehearing en banc in Biogen Int'l GmbH v. Mylan Pharmaceuticals Inc. Judges Cunningham and Stoll did not participate in the decision, which was issued per curiam and supported…
-
November 30, 2021 – "Trends in Patent Prosecution: Don’t Get Left Behind" (LexisNexis and IPWatchdog) – 2:00 pm (ET) December 2, 2021 – "The Intersection of Intellectual Property and International Arbitration: Quantum and Valuation (Part 1)" (Lexology, iam, GAR, and Charles Rivers Associates) – 8:00 am to 9:30 am (CST) December 3, 2021 – "PTAB…
-
By Kevin E. Noonan — The Federal Trade Commission carried out an (in)famous crusade against reverse payment (more provocatively, "pay for delay") settlements in ANDA litigation for almost a decade before eventually having the Supreme Court see things their way (to some extent) in FTC v Actavis. The Commission has not lost its enthusiasm for…
Patent Docs 